Does metformin affect outcomes in COVID‐19 patients with new or pre‐existing diabetes mellitus? A systematic review and meta‐analysis

AIMS: The COVID‐19 pandemic is a global public health emergency and patients with diabetes mellitus (DM) are disproportionately affected, exhibiting more severe outcomes. Recent studies have shown that metformin is associated with improved outcomes in patients with COVID‐19 and DM and may be a poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesh, Adithan, Randall, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111510/
https://www.ncbi.nlm.nih.gov/pubmed/35122284
http://dx.doi.org/10.1111/bcp.15258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111510/
https://www.ncbi.nlm.nih.gov/pubmed/35122284
http://dx.doi.org/10.1111/bcp.15258

Ejemplares similares